A machine learning (ML) approach for identifying genetic biomarkers and new molecular targets associated with impaired survival of breast cancer patients

BACKGROUND Machine learning (ML) tools are suitable to dive vast amounts of clinical and genetic information in order to identify genetic biomarkers of worse survival and potential new molecular targets. This study has investigated the ability of one such tool to identify genetic biomarkers associated with higher risk of mortality in breast cancer, biomarkers that…

Prospective evaluation of SkinGuard, a deep algorithmic framework for the classification of neoplastic skin lesions

Introduction. Diagnostic errors between nevic lesions and skin tumors are frequent for non-specialist physicians. Therefore, there is a need to create a simple and practical tool based on artificial intelligence to assists them in distinguishing potentially malignant lesions from benign ones, improving early detection of skin cancer. Objective. To evaluate the performance of SkinGuard, an…

Harnessing the power of AI and HTE, cloud lab and automation data to transform drug discovery

Drug discovery is a lengthy and costly process affected by a high attrition rate. The revolution in experimental sciences brought about by HTE, cloud labs and lab automation should represent an excellent opportunity to completely transform drug discovery and overcome the serious problems that hinder the process. But this transformation will not be possible without…